MedImmune Ventures, Inc., 10% Owner at G1 Therapeutics, Inc. (GTHX), sold 200,000 shares at $19.75 ($4.0M) on 2017-12-15, disclosed to the SEC on 2017-12-18.
Open-market sale of $4.0M GTHX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| GTHX | SELL | 2017-11-22 | $8.0M | — | Filing → |
| GTHX | BUY | 2017-05-24 | $1.1M | — | Filing → |
| CATB | BUY | 2015-06-30 | $2.7M | — | Filing → |